Morgan Stanley Knock-Out R66/ DE000MB7YAR1 /
19/06/2024 19:49:30 | Chg.-0.07 | Bid20:29:37 | Ask20:29:37 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
6.76EUR | -1.02% | 6.75 Bid Size: 500 |
6.86 Ask Size: 500 |
PHILLIPS 66 D... | 62.9841 - | 31/12/2078 | Call |
GlobeNewswire
17/06
Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2024 Earnings Conference Call
GlobeNewswire
17/06
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
12/06
Greystone Closes $22.9 Million in Total Debt Placement and Preferred Equity Financing for Fort Worth...
GlobeNewswire
05/06
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
29/05
Phillips Edison & Company to Present at Nareit REITweek 2024 Investor Conference
GlobeNewswire
22/05
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire
20/05
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease We...
GlobeNewswire
16/05
Optimal Daily Dairy Consumption Remains Elusive Despite Well-Established Health Benefits
GlobeNewswire
16/05
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
15/05
King Fuels Announces Strategic Expansion of Its Fuel Distribution Network in Texas, Colorado, Kansas...
GlobeNewswire
14/05
Kontrolmatik Technologies and Pomega Standardize Operations With Siemens Solutions and Form an Engin...
GlobeNewswire
13/05
Safe Boating Campaign’s Annual National Safe Boating Week Celebrates All Boaters This May 18-24, 202...
GlobeNewswire
10/05
First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Marke...
GlobeNewswire
09/05
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness ...